Your session is about to expire
← Back to Search
High Dose Albumin for Ascites
Study Summary
This trial is studying how regular albumin infusion might improve survival and reduce complications in cirrhotic patients with ascites.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2012 Phase 4 trial • 29 Patients • NCT00108355Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My ascites hasn't improved despite maximum diuretic treatment and needs frequent draining.I have never had liver cirrhosis.I have fluid in my abdomen not caused by heart or cancer issues.I am older than 18 years.I have been diagnosed with liver cirrhosis.I am under 18 years old.I have ascites not responding to treatment and got a TIPS procedure within the last 3 months.
- Group 1: Intervention arm
- Group 2: Control arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
To what extent might the Intervention arm pose a threat to patients?
"Our team's assessment of Intervention arm safety is a 2, as its Phase 2 status implies there are some data that indicate security but no evidence yet showing effectiveness."
How many participants are presently enrolled in this clinical experiment?
"Affirmative. Per the information published on clinicaltrials.gov, this medical research is actively enrolling patients; it was initially posted March 25th 2019 and its latest update was May 10th 2023. The study necessitates 100 participants to be sourced from one site of recruitment."
Are there still opportunities for volunteers to enter this clinical investigation?
"Yes, the information hosted on clinicaltrials.gov affirms that this research endeavour is currently recruiting patients; it was initially published on March 25th 2019 and modified most recently in May 10th 2023. This trial requires a total of 100 participants from one medical centre."
What are the primary goals of this research project?
"Over the course of one year, this clinical trial will track and measure the primary outcome of liters per albumin administration. This is supplemented by secondary evaluations that include diuretics dosage assessment, liver-related quality of life analysis, and mortality rate after 12 months."
Share this study with friends
Copy Link
Messenger